EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epigallocatechin-3-Gallate Triggers Mitochondrial-Mediated Apoptosis and Suppresses EGFR Signaling in Cervical Cancer Cells

Mahtab Zarei Moradi, Shabnam Zarei Moradi, Zahra Ghasemi, Hamid Ghahramani, Kiumarth Amini

Gene, Cell and Tissue · 31.01.2026 · 13 (1)

DOI: 10.5812/gct-168391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gene, Cell and Tissue, online erschienen am 31.01.2026. Verfasst von Mahtab Zarei Moradi und 4 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cervical cancer is associated with a relatively high mortality rate in women. Conventional therapies often cause significant adverse effects, highlighting the need for novel treatments with improved safety and efficacy.

Objectives

Considering that epigallocatechin-3-gallate (EGCG) has anticancer effects in various malignancies, this study evaluated the impacts of EGCG on cervical cancer cells, with emphasis on identifying the mechanism of action.

Methods

After culture, HeLa and CaSki cells were exposed to a range of EGCG concentrations. The MTT assay was used to assess cell viability, and flow cytometry was used for apoptosis. Finally, using designed primers, expression levels of bax, CASP3, p53, bcl-2, CASP9, and EGFR were quantified by qRT-PCR.

Results

The EGCG decreased cell viability in both cervical cancer cell lines and increased apoptosis. Notably, at 40 and 80 μg/mL, EGCG upregulated pro-apoptotic genes (bax, p53, CASP3, CASP9) and downregulated anti-apoptotic bcl-2 and EGFR expression.

Conclusions

Our findings indicate that EGCG exerts anticancer activity against cervical cancer cell lines, at least in part, by activating the intrinsic mitochondrial apoptosis pathway as well as inhibiting proliferative signaling. Further mechanistic research is needed to determine the full spectrum of EGCG’s actions in cervical cancer.

Zitieren

APA

Moradi, M. Z., Moradi, S. Z., Ghasemi, Z., Ghahramani, H., & Amini, K. (2026). Epigallocatechin-3-Gallate Triggers Mitochondrial-Mediated Apoptosis and Suppresses EGFR Signaling in Cervical Cancer Cells. Gene, Cell and Tissue, 13(1). https://doi.org/10.5812/gct-168391

Vancouver

Moradi MZ, Moradi SZ, Ghasemi Z, Ghahramani H, Amini K. Epigallocatechin-3-Gallate Triggers Mitochondrial-Mediated Apoptosis and Suppresses EGFR Signaling in Cervical Cancer Cells. Gene, Cell and Tissue. 2026;13(1). doi:10.5812/gct-168391

BibTeX
@article{Moradi2026,
  author = {Moradi, Mahtab Zarei and Moradi, Shabnam Zarei and Ghasemi, Zahra and Ghahramani, Hamid and Amini, Kiumarth},
  title = {Epigallocatechin-3-Gallate Triggers Mitochondrial-Mediated Apoptosis and Suppresses EGFR Signaling in Cervical Cancer Cells},
  journal = {Gene, Cell and Tissue},
  year = {2026},
  volume = {13},
  number = {1},
  doi = {10.5812/gct-168391}
}
Kostenlos starten →